Related Experiment Video
Updated: Feb 8, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Sensitization of prostate cancer to radiation therapy: Molecules and pathways to target
Mu Yao1, Linda Rogers2, Natalka Suchowerska2
1Central Clinical School and Charles Perkins Centre, Australia; Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia.
Abstract:
Radiation therapy is used to treat cancer by radiation-induced DNA damage. Despite the best efforts to eliminate cancer, some cancer cells survive irradiation, resulting in cancer progression or recurrence. Alteration in DNA damage repair pathways is common in cancers, resulting in modulation of their response to radiation. This article focuses on the recent findings about molecules and pathways that potentially can be targeted to sensitize prostate cancer cells to ionizing radiation, thereby achieving an improved therapeutic outcome.
Insights
Targeting DNA repair pathways can sensitize prostate cancer cells to radiation therapy. This approach aims to improve treatment outcomes by preventing cancer recurrence after irradiation.
Area of Science:
- Oncology
- Radiation Biology
- Molecular Biology
Background:
- Radiation therapy is a cornerstone of cancer treatment, inducing DNA damage to eliminate malignant cells.
- Cancer cell survival post-irradiation contributes to disease progression and recurrence.
- Aberrant DNA damage repair pathways in cancer cells influence their response to radiation therapy.
Purpose of the Study:
- To review recent findings on molecular targets and pathways for sensitizing prostate cancer cells to ionizing radiation.
- To explore strategies for improving therapeutic outcomes in prostate cancer treatment.
Main Methods:
- Literature review of recent research on DNA damage repair pathways in prostate cancer.
- Analysis of molecular targets and signaling pathways involved in radioresistance.
- Focus on strategies to enhance the efficacy of ionizing radiation.
Main Results:
- Identified key molecules and pathways that can be targeted to overcome radioresistance in prostate cancer.
- Highlighted the role of altered DNA damage repair in modulating radiation response.
- Provided insights into potential therapeutic strategies for improved outcomes.
Conclusions:
- Targeting specific molecules and pathways involved in DNA repair presents a promising strategy to sensitize prostate cancer to radiation.
- Enhancing the radiosensitivity of prostate cancer cells can lead to improved therapeutic efficacy and reduced recurrence.
- Further research into these targets may pave the way for novel combination therapies.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Biological Effects of Radiation
Radiation: Applications
The average...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Absorption of Radiation